RLMD
RELMADA THERAPEU (RLMD)
NASDAQ
$6.82+$0.05 (+0.80%)
Price as of Jun 23, 2026 6:59 PM EDT
  • $722.7M
    Market Cap
  • 1,043.77%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
JANUS HENDERSON GROUP PLC
15.09%
11.1M
+3.8M (+34.29%)
Mar 31, 2026
N/A
11.56%
8.5M
+1.8M (+20.94%)
Mar 31, 2026
VR ADVISER, LLC
6.60%
4.8M
+4.8M (+100.00%)
Mar 31, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.
6.50%
4.8M
+493,158 (+10.35%)
Mar 31, 2026
ORBIMED ADVISORS LLC
6.43%
4.7M
+2.1M (+44.64%)
Mar 31, 2026
MARSHALL WACE, LLP
6.11%
4.5M
+1.3M (+28.83%)
Mar 31, 2026
MILLENNIUM MANAGEMENT LLC
5.33%
3.9M
+2.2M (+57.18%)
Mar 31, 2026

Current Ownership Distribution

  • Institutions369.5M (88.30%)
  • Mutual Funds44.1M (10.53%)
  • Insiders4.9M (1.17%)
  • Other0 (0.00%)

Insider Transactions

  • 1.17% (4.9M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
No data found

No data found